Literature DB >> 9675019

Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.

K J Rees-Milton1, Z Jia, N C Green, M Bhatia, O El-Kabbani, T G Flynn.   

Abstract

The only major structural difference between aldehyde reductase, a primarily NADPH-dependent aldo-keto reductase, and aldose reductase, a dually coenzyme-specific (NADPH/NADH) member of the same superfamily, is an additional eight amino acid residues in the substrate/inhibitor binding site (C-terminal region) of aldehyde reductase. On the premise that this segment defines the substrate specificity of the enzyme, a mutant of aldehyde reductase lacking residues 306-313 was constructed. In contrast to wild-type enzyme, the mutant enzyme reduced a narrower range of aldehydes and the new substrate specificity was not similar to aldose reductase as might have been predicted. A major change in coenzyme specificity was observed, however, the mutant enzyme being distinctly NADH preferring(Km, NADH = 35 microM, compared to <5 mM for wild-type and Km, NADPH = 670 microM, compared to 35 microM for wild type). Upon analyzing coordinates of aldehyde and aldose reductase, we found that deletion of residues 306-313 may have created a truncated enzyme that retained the three-dimensional structural features of the enzyme's C-terminal segment. The change in substrate specificity could be explained by the new alignment of amino acids. The reversal of coenzyme specificity appeared to be due to a significant backbone shift initiated by the formation of a strong hydrogen bond between Tyr319 and Val300. A similar bond exists in aldose reductase (Tyr309-Ala299). It appears, therefore, that as far as coenzyme specificity is concerned, deletion of residues 306-313 has converted aldehyde reductase into an aldose reductase-like enzyme. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675019     DOI: 10.1006/abbi.1998.0721

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Functional expression of novel human and murine AKR1B genes.

Authors:  Joshua K Salabei; Xiao-Ping Li; J Mark Petrash; Aruni Bhatnagar; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen.

Authors:  Jean-François Couture; Karine Pereira de Jésus-Tran; Anne-Marie Roy; Line Cantin; Pierre-Luc Côté; Pierre Legrand; Van Luu-The; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

Review 3.  Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

Authors:  Ravichandran Ramasamy; Ira J Goldberg
Journal:  Circ Res       Date:  2010-05-14       Impact factor: 17.367

4.  Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases.

Authors:  Kathryn L Kavanagh; Mario Klimacek; Bernd Nidetzky; David K Wilson
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

5.  The coenzyme specificity of Candida tenuis xylose reductase (AKR2B5) explored by site-directed mutagenesis and X-ray crystallography.

Authors:  Barbara Petschacher; Stefan Leitgeb; Kathryn L Kavanagh; David K Wilson; Bernd Nidetzky
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

Review 6.  Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.

Authors:  Sravya Jannapureddy; Mira Sharma; Gautham Yepuri; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.